Glucose sensing in the pancreatic beta cell: a computational systems analysis by Leonid E Fridlyand & Louis H Philipson
Fridlyand and Philipson Theoretical Biology and Medical Modelling 2010, 7:15
http://www.tbiomed.com/content/7/1/15
Open AccessR E S E A R C HResearchGlucose sensing in the pancreatic beta cell: a 
computational systems analysis
Leonid E Fridlyand* and Louis H Philipson
Abstract
Background: Pancreatic beta-cells respond to rising blood glucose by increasing oxidative 
metabolism, leading to an increased ATP/ADP ratio in the cytoplasm. This leads to a closure 
of KATP channels, depolarization of the plasma membrane, influx of calcium and the 
eventual secretion of insulin. Such mechanism suggests that beta-cell metabolism should 
have a functional regulation specific to secretion, as opposed to coupling to contraction. 
The goal of this work is to uncover contributions of the cytoplasmic and mitochondrial 
processes in this secretory coupling mechanism using mathematical modeling in a 
systems biology approach.
Methods: We describe a mathematical model of beta-cell sensitivity to glucose. The 
cytoplasmic part of the model includes equations describing glucokinase, glycolysis, 
pyruvate reduction, NADH and ATP production and consumption. The mitochondrial part 
begins with production of NADH, which is regulated by pyruvate dehydrogenase. NADH is 
used in the electron transport chain to establish a proton motive force, driving the F1F0 
ATPase. Redox shuttles and mitochondrial Ca2+ handling were also modeled.
Results: The model correctly predicts changes in the ATP/ADP ratio, Ca2+ and other 
metabolic parameters in response to changes in substrate delivery at steady-state and 
during cytoplasmic Ca2+ oscillations. Our analysis of the model simulations suggests that 
the mitochondrial membrane potential should be relatively lower in beta cells compared 
with other cell types to permit precise mitochondrial regulation of the cytoplasmic ATP/
ADP ratio. This key difference may follow from a relative reduction in respiratory activity. 
The model demonstrates how activity of lactate dehydrogenase, uncoupling proteins and 
the redox shuttles can regulate beta-cell function in concert; that independent oscillations 
of cytoplasmic Ca2+ can lead to slow coupled metabolic oscillations; and that the relatively 
low production rate of reactive oxygen species in beta-cells under physiological conditions 
is a consequence of the relatively decreased mitochondrial membrane potential.
Conclusion: This comprehensive model predicts a special role for mitochondrial control 
mechanisms in insulin secretion and ROS generation in the beta cell. The model can be 
used for testing and generating control hypotheses and will help to provide a more 
complete understanding of beta-cell glucose-sensing central to the physiology and 
pathology of pancreatic β-cells.
Background
The appropriate secretion of insulin from pancreatic β-cells is critically important for
energy homeostasis. Pancreatic β-cells are adapted to sense blood glucose and other secret-
agogues to adjust insulin secretion according to the needs of the organism. Rather than acti-
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Page 2 of 44vating specific receptor molecules, glucose is metabolized to generate downstream
signals that stimulate insulin secretion. Pancreatic β-cells respond to rising blood glu-
cose by increasing oxidative metabolism, leading to increased ATP production in mito-
chondria and in an enhanced ratio of ATP to ADP (ATP/ADP) in the cytoplasm [1-3].
The increase in intracellular ATP/ADP closes the ATP-sensitive K+ channels (KATP),
decreasing the hyperpolarizing outward K+ flux. This results in depolarization of the
plasma membrane, influx of extracellular Ca2+ through the voltage-gated Ca2+ channels,
a sharp increase in intracellular Ca2+ and activation of protein motors and kinases, which
then mediate exocytosis of insulin-containing vesicles [2-5]. The currently accepted pro-
cesses of glucose metabolism and Ca2+ handling in the cytoplasm and mitochondria of β-
cells considered in this analysis are summarized in Figure 1[1-4].
A brief summary of these processes includes the following steps. Glucose enters β-cells
by facilitated diffusion through glucose transporters (GLUT1 and 2). While this process
is not limiting in β-cells [6], the next irreversible step, glucose phosphorylation, is cata-
lyzed by a single enzyme, glucokinase (GK). This enzyme is specific for metabolic con-
trol in the β-cell and hepatocyte, because the Km of GK for glucose is ~8 mM, a value that
is almost two orders of magnitude higher than that of any other hexokinase. This step
appears to be rate limiting for β-cell glycolytic flux under normal physiological condi-
tions, so that GK is regarded as the β-cell 'glucose sensor' [1,3], underlying the depen-
dence of the β-cell insulin secretory response to glucose in the physiological range.
Pyruvate is the main end product of glycolysis in β-cells and essential for mitochon-
drial ATP synthesis. In the mitochondrial matrix, pyruvate is oxidized by pyruvate dehy-
drogenase to form acetyl-coenzyme A (acetyl-CoA). Acetyl-CoA enters the tricarboxylic
acid (TCA) cycle to undergo additional oxidation steps generating CO2 and the reducing
equivalents, flavin adenine dinucleotide (FADH2) and NADH. Oxidation of reducing
equivalents by the respiratory chain is coupled to the extrusion of protons from the
matrix to the outside of the mitochondria, thereby establishing the electrochemical gra-
dient across the inner mitochondrial membrane (Figure 1). The final electron acceptor of
these reactions is molecular oxygen, as in other eukaryotic cells. The electrochemical
gradient then drives ATP synthesis at the F1F0-ATPase complex to phosphorylate mito-
chondrial ADP, thereby linking respiration to the synthesis of ATP from ADP and inor-
ganic phosphate (Figure 1). Adenine nucleotide translocase (ANT) exchanges matrix
ATP for ADP to provide ATP for energy consuming processes in the cytosol. Some cyto-
solic ATP is also produced in the latter part of glycolysis. However, this appears to be of
minor consequence relative to that subsequently generated in the mitochondria, which
represents an estimated 90% of the total β-cell ATP production [7,8].
The cytoplasmic Ca2+ signal is coupled to mitochondrial Ca2+ handling (Figure 1). The
balance of Ca2+ influx and efflux determines the matrix Ca2+ level involving the Ca2+ uni-
porter and the mitochondrial Na+/Ca2+ exchanger, respectively. Ca2+ influx into mito-
chondria is amplified by hyperpolarization of the inner mitochondrial membrane [9,10].
Inside the organelle, Ca2+ activates several matrix dehydrogenases (for example, pyruvate
dehydrogenase). Mitochondrial Ca2+ may also directly stimulate ATP synthase [11]. The
nutrient-dependent Ca2+ rise in the cytosol further activates ATP hydrolysis [7,10,12,13].
An important β-cell specialization is the very low expression of lactate dehydrogenase
(LDH), the enzyme catalyzing the conversion of pyruvate to lactate [1,14,15]. A low level
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vate towards mitochondrial metabolism (see [1,10,16]). However, the low LDH levels
likely leads to activation of compensatory mechanisms because NAD+-dependent glyco-
lytic enzymes (e.g., glyceraldehyde 3-phosphate dehydrogenase) require that cytoplas-
mic NADH must be re-oxidized to NAD+. This reaction is usually catalyzed by LDH, but
because β-cells cannot use this pathway effectively, these cells must re-oxidize cytoplas-
mic NADH by activation of two mitochondrial hydrogen shuttles (Figure 1), the malate-
aspartate shuttle and the glycerol phosphate shuttle [15,17-19].
Figure 1 Schematic diagram of biochemical pathways involved in energy metabolism and Ca2+ han-
dling in the pancreatic β-cell. Glucose equilibrates across the plasma membrane and is phosphorylated by 
glucokinase to glucose 6-phosphate, which initiates glycolysis. Lactate dehydrogenase (LDH) converts a por-
tion of pyruvate to lactate. Pyruvate produced by glycolysis preferentially enters the mitochondria and is me-
tabolized in the tricarboxylic acid (TCA) cycle, which then yields reducing equivalents in the form of NADH and 
FADH2. The transfer of electrons from these reducing equivalents through the mitochondrial electron trans-
port chain is coupled with the pumping of protons from the mitochondrial matrix to the intermembrane 
space. The resulting transmembrane electrochemical gradient drives the ATP synthesis at ATP-synthase. Part 
of the protons may leak back through uncoupling proteins (UCPs). The shuttle systems are required for the 
transfer of reducing equivalents from the cytoplasm to the mitochondrial matrix. Calcium handling proteins 
such as the uniporter and Na+/Ca2+ exchanger regulate Ca2+ handling in mitochondria. ATP is transferred to the 
cytosol, raising the ATP/ADP ratio. This results in the closure of the ATP sensitive K+ channels (katp), which in 
turn leads to depolarization of the cell membrane. In response, the voltage-sensitive Ca2+ channels open, pro-
moting calcium entry and increasing the cytoplasmic Ca2+. ATPc and ADPfree are the free cytosolic form of ATP 
and ADP, G3P is the glyceraldehydes 3-phosphate, PDH is the pyruvate dehydrogenase, ANT is the adenine nu-
cleotide translocase, Ψm is the mitochondrial membrane potential. Solid lines indicate flux of substrates, and 
dashed lines indicate regulating effects, where (+) represents activation and (-) repression.
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multiple oscillations in metabolism, mitochondrial membrane potential Ψm) and
NADH, mitochondrial and cytoplasmic Ca2+ and, ultimately, the oscillations of insulin
secretion [5,20-23]. The coupling of these various oscillators is not clearly understood. In
addition, the respiratory rate is lower and relative leak activity is higher in isolated β-cell
mitochondria (as found in a cultured β-cell line) compared with isolated mitochondria
from skeletal muscle [24,25]. These observations need clarification to better understand
how mitochondrial processes are linked with insulin secretion.
The unique character of the β-cell response to glucose is usually attributed solely to
glucokinase. Because of its near-dominant control of glycolytic flux, this enzyme is
thought to govern the ATP/ADP ratio and insulin secretion almost exclusively [1,3].
While glucokinase certainly exerts a critical level of control on downstream events, other
cytoplasmic and mitochondrial processes also play an essential role in glucose-stimu-
lated insulin secretion (GSIS) [1,2,10]. In particular the relatively high flexibility of the
ATP/ADP ratio in β-cells may be accounted for, at least partly, by mitochondrial pecu-
liarities as well as by properties of glucokinase [24,26,27]. For these reasons it is critical
to develop a comprehensive understanding as to how cytoplasmic and intramitochon-
drial fuel metabolism is coupled to fuel availability and thereby "sensed."
The goal of this work is to determine the contribution of the cytoplasmic and mito-
chondrial processes regulating GSIS using a mathematical modeling approach. Mathe-
matical modeling can be a powerful systems biology tool allowing quantitative
descriptions of the control individual components exert over the whole biological sys-
tem. Several mathematical approaches in the literature have provided quantitative esti-
mates of energetic and mitochondrial processes in pancreatic β-cells. However, these
models are limited in the pathways that are considered, so that a more comprehensive
approach is now necessary.
The first detailed β-cell model was developed by Magnus and Keizer [28-30]. However,
several mechanisms used for simulations in this model have recently been reevaluated.
For example, steady-state electron transport and the F1F0 ATPase proton pump were
modeled according to the "six states proton pump mechanism" [28]. This mechanism
does not correspond to the present understanding of the function of the electron trans-
port chain (ETC) and the mitochondrial F1F0 adenosine trisphosphatase (see for example
[31]). Models of the LDH and NADH shuttles were not included, and mitochondrial
fluxes may also have been overestimated in this model (see below). The main goal of
these models was to examine the possible mechanisms underlying oscillations in pancre-
atic β-cells, not biochemical regulation of β-cell glucose sensitivity that we are focused
on here.
A complex kinetic model of the metabolic processes in pancreatic β-cells based on in
vitro enzyme kinetics was recently developed [32]. However, while heroically compli-
cated models with numerous parameters and enzyme activities are interesting, they
require data on in vivo enzyme activities and coefficients that are not readily available.
Enzyme activity measurements in vitro, often used in models, may not reflect enzyme
activity in vivo [33]. For example, experimental kinetic data for isolated mitochondria
and the parameters evaluated for mitochondrial processes from experiments with intact
cells may differ significantly [34]. For these and other reasons previous models of pancre-
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explanation of the mechanisms of β-cell sensitivity.
To address this we have developed a specific quantitative, kinetic model (see Appen-
dix) of the core processes of β-cell cytoplasmic and mitochondrial energetic based on a
simplified map of the biochemical pathways schematized in Figure 1. We included the
most recent experimental characterizations of the majority of processes in the model to
insure accuracy. However, for simplification, we modeled only those regulatory cou-
plings that we have deemed most crucial for the β-cell metabolic regulation based on
experimental evidence. The model includes the dynamic equations for cytoplasmic ADP,
NADH and glyceraldehyde 3-phosphate, mitochondrial Ψm and NADH, mitochondrial
and cytoplasmic Ca2+ and pyruvate. When available we used the values of the coeffi-
cients determined for living cells rather than for isolated enzymes and cell-free mito-
chondria (Appendix).
We show that this model has qualitative properties consistent with expectations for the
pancreatic β-cell including showing appropriate oscillations in mitochondrial metabo-
lism and Ca2+ concentration. The model also reproduces simultaneous measurements of
the behavior of multiple constituents within the cytoplasm and mitochondria such as
NADH, Ca2+ and Ψm at high temporal resolution. We also discuss specific differences in
muscle and β-cell mitochondrial function, providing insight into essential control prop-
erties of the β-cell. Furthermore, predictions on the dynamics of as yet unmeasured mol-
ecules could be made, and the model further tested by verifying these predictions.
Nutrient-stimulated insulin secretion in β-cells is impaired in the diabetic state. This
may result from impaired glucose-induced ATP/ADP ratio elevation in β-cells [26,35].
Furthermore, it is becoming increasingly clear that the development of type 2 diabetes is
associated with mitochondrial dysfunction [27,35-37]. Insulin signaling also effects
mitochondrial function in β-cells [38]. Thus, knowledge of the mechanisms of regulation
of ATP production and consumption are central to understand β-cell glucose-sensing
and mechanisms of dysfunction in type 2 diabetes.
Results and Discussion
Steady state stimulation with a step increase in glucose concentration
The model was used to simulate data obtained using several experimental protocols.
Under resting low glucose concentration the simulated values of the cytoplasmic and
mitochondrial variables are consistent with experimentally reported data as indicated in
Table 1. Then the model was used to examine the steady-state changes of the state vari-
ables and fluxes. Figure 2 shows the responses of model simulation to steps in the glu-
cose concentration observed in successive steady-states. Glucokinase catalyzed the rate-
limiting step of glycolysis with a steep dependence on glucose concentration in the range
4-25 mM. Enhancement of glucose concentration led to an increase in glycolytic flux,
glyceraldehyde 3-phosphate (G3P) and pyruvate concentrations (Figure 2A,B). This pro-
cess accelerated pyruvate reduction and decarboxylation leading to increased [NADH]m
(Figure 2B). [NADH]m was oxidized by the ETC, raising the rate of mitochondrial O2
consumption. Oxidation of mitochondrial NADH by the respiratory chain increased the
membrane potential directly via protons pumped out of the matrix. Ψm was dissipated by
proton-leak reactions and the activity of the phosphorylation apparatus, which included
the phosphate carrier and the ATP synthase (Figure 1). The net result of these processes
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membrane resulted in increased ATP production by F1F0 ATPase, decreased [ADP]c and
a corresponding increased ATP/ADP ratio (Figure 2D). The phosphorylation rate (Jph)
reached saturation at high glucose concentration (Figure 2C) as a consequence of
decreased [ADP]c and saturated Ψm(see Equation 7 and Figure 12 in Appendix). Simul-
taneously, [Ca2+]c increased with increased ATP/ADP ratio according to the empirical
Equation 23 (Appendix). We also simulated the steady-state response of free mitochon-
drial matrix Ca2+ to changes in cytoplasmic Ca2+ concentration, Ψm and finally glucose
(Figure 2E).
As expected, our simulations were consistent with experimental data. Glucose utiliza-
tion increased lactate synthesis, O2 consumption and CO2 production [1,7,39,40]. Both
cellular [G3P] and [PYR] increased after simulating increased extracellular glucose (Fig-
ure 2B). This result is consistent with the finding of increased glycolytic intermediates
and pyruvate after glucose challenge in the INS1 β-cell line [41] as well as the increase in
Ψm with increased glucose in mouse islets [20-22,42-44].
An accurate measurement of lactate output in β-cells from isolated islets is difficult to
obtain because LDH expression in non-β-cells is considerably higher than in β-cells, and
high rates of lactate output may also originate from cells in the centers of isolated islets
that are prone to oxygen depletion and necrosis [39,45]. However, the oxidative produc-
tion of CO2 from [3,4-14C]glucose represented close to 100% of the total glucose utiliza-
tion in purified rat β-cells [39] indicating that lactate output should not exceed several
percent. Very low lactate output was also found in β-cell lines [46]. Our simulated small
lactate output in Figure 2A is consistent with these experimental data.
The results of the simulation (Table 1 and Figure 2B) were also consistent with the
range of measured [NADH]m reported previously. For example, the concentration of free
NADH in mitochondria of intact pancreatic islets at resting glucose levels (4-5 mM) is
about 60 μM and the maximum mitochondrial glucose-induced increase in free
NAD(P)H reached 75 μM [47]. The simulated increased [Ca2+]c versus glucose concen-
tration (Figure 2E) was also in agreement with previous reports (see for example [42,48-
50]).
Several studies have confirmed an increase in the ATP/ADP ratio in response to high
glucose (see for e.g. [3,7,12,26,51]. A simultaneous rise in ATP/ADP and NADH/(NAD+
+ NADH) ratio was found in rat islets [52], and NAD+/NADH was increased in rat β-
Table 1: Stimulated steady-state values for low glucose (5 mM) (see text for explanations)
Parameters Simulated value Experimental value References
[Ca2+]c 0.09 μM ~0.1 μM [49,52]
[G3P] 2.79 μM
[PYR] 8.62 μM
[ATP]c/[ADP]c 4.6 ~3 - 6 [7,12,51]
[NADH]c 0.97 μM
Ψm 94.7 mV
[NADH]m 57.2 μM 60 μM [47]
[Ca2+]m 0.242 μM 0.25 μM [48]
Fridlyand and Philipson Theoretical Biology and Medical Modelling 2010, 7:15
http://www.tbiomed.com/content/7/1/15
Page 7 of 44
Figure 2 Effect of increasing glucose on cell energetics. Extracellular glucose concentration was varied and 
the steady-state simulations of the model parameters represented. Simulations were run with the basic set of 
parameters (Tables 2 and 3). A: Jglu is the rate of the glucokinase reaction (for comparison with other fluxes the 
amount of 2 Jglu is represented since two pyruvate molecules are synthesized from one molecule of glucose), 
jpyr is the rate of pyruvate decarboxylation, jtnadh is the flux through the NADH shuttles measured as the rate 
of cytoplasmic NAD+ production from cytoplasmic NADH, JLDH is the lactate flux catalyzed by lactate dehydro-
genase; B: [NADH]c and [NADH]m are cytoplasmic and mitochondrial NADH, [Pyr] is the pyruvate concentration, 
[G3P] is the cytoplasmic glyceraldehydes 3-phosphate concentration; C: Jhres is the rate of proton pumping 
through ETC, Jph is the proton flux through the F1F0 ATPase, Jhi is the leak of protons from mitochondria; D: Ψm 
is the mitochondrial membrane potential, [ATP]c/[ADP]c is the cytoplasmic ATP/ADP ratio; E: [Ca2+]c and [Ca2+]m 
are the concentration of free Ca2+ in cytoplasm and mitochondria.
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ratio as well as in relative NAD(P)H, Ψm, [Ca2+]m and oxygen consumption were also
observed with glucose stimulation in control INS-1 cells [54,55]. Our simulations are
generally consistent with these data.
Regulation at the mitochondrial level
The model suggests a possible reconciliation of several apparent contradictions between
live cell experimental data and regulation of mitochondrial energetics obtained in exper-
iments with isolated mitochondria.
1. A basic principle of mitochondrial energetics is given by the inverse relationship
between the respiratory flux and Ψm, i.e. the higher Ψm, the lower the respiration rate
[24,56]. We simulated this relationship using Equation 5C (Appendix). However, the
electron transport rate (Jhres) and O2 consumption increased simultaneously with Ψm in
our simulation of the β-cell (see Figure 2C) as well as in vivo (see above). The model
offers the following explanation of this contradiction. In our model (as in living cells) the
electron transport rate (Equation 5) depends on at least two factors: one is a decrease in
the electron transport rate with an increase in Ψm (Equation 5C) but another factor is an
increase of this rate with increased substrate concentration (NADH) (Equation 5A).
Increasing the electron transport rate simultaneously with Ψm means that the enhance-
ment of Jhres as a result of the increased [NAPH]m was greater than its decrease with the
rise of Ψm following the step increase in glucose. Substrate concentrations are usually
maintained at constant or saturated levels in experiments with isolated mitochondria,
where one can only see inhibition of the electron transport rate with increased Ψm.
2. The respiratory control hypothesis for ATP production in intracellular mitochon-
dria was based on experiments with isolated mitochondria which found that ADP avail-
ability to the ATP-synthase is the limiting factor for mitochondrial ATP production [57],
that is, the rate of ATP synthesis should decrease with decreased [ADP]c. This mecha-
nism corresponds to Equation 7A in our model. Experimentally this hypotheses has been
tested in permeabilized clonal β-cells, where ATP/ADP ratios can be externally fixed
showing that a decrease in [ADP] led to decreased O2 consumption [3]. However, an
increased ATP/ADP ratio (usually due to decreased [ADP]c) coincidentally with
increased respiration rate and oxidative phosphorylation has been firmly established for
pancreatic β-cells as a signal for GSIS in response to increased glucose
[1,3,7,12,26,51,55]. Similar results were obtained in our simulation of β-cell shown in
Figure 2D. At first glance these data seem inconsistent with the expected inhibition of
respiration with decreased ADP concentration [3,55].
Our analysis resolves this apparent contradiction. In our model the ATP synthesis rate
is dependent on at least two factors: one is a decreased ATP synthesis rate with
decreased [ADP]c (Equation 7A) but another factor is an increased ATP synthesis rate
with increased Ψm(Equation 7B). Our simulation shows that enhancement of ATP pro-
duction with increasing Ψm was greater than its decrease as a result of decreasing [ADP]c
following a step increase in glucose. As a result, ATP synthesis and respiration rate
increase despite decreased [ADP]c and the ATP/ADP ratio increased with a step glucose
increase (Figure 2D). These simulations imply that glucose challenge can lead to simulta-
neous increases in Ψm, the ATP/ADP ratio and in the rates of mitochondrial ATP syn-
thesis and respiration.
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since only free molecules can take part in reactions. However, the free ATP concentra-
tion is close to its total concentrations, whereas the fraction of bound ADP may be sub-
stantial [58,59]. On the other hand, most estimated ATP/ADP ratios are based on
measurements of total nucleotide content [7,12,51]. For this reason, the measured ATP/
ADP ratio of total ATP and ADP nucleotide content is likely to be substantially smaller
than ratio of concentration of the free components, simply because the measured total
ADP content includes bound ADP. Therefore, it is not surprising that the simulated
ATP/ADP ratio change in Figure 2D using free nucleotide concentrations is greater than
that in published experimental data (see for example [7,12,51].
According to our simulation only a small increase in the ATP concentration occurred
following glucose challenge (not shown). A decrease in the free [ADP]c is the main factor
leading to an increase in the ATP/ADP ratio following increased glucose in Figure 2D.
This simulation is in agreement with experimental data and can be a consequence of the
initial high ATP/ADP ratio even with a low glucose level in our model (see Table 1). For
this reason, the ATP concentration cannot be increased significantly if the total adenine
nucleotide concentration is kept constant, whereas the relative [ADP] may undergo a
pronounced decrease (see our previous publication [26] for a detailed consideration of
this question).
Decreased Ψm and respiratory activity regulate mitochondrial glucose sensitivity in β-cells
β-cell regulatory mechanisms endow this cell type with unique metabolic properties to
control insulin secretion in comparison with metabolism in other cell types. For exam-
ple, liver cells maintain a stable ATP/ADP equilibrium while respiring at widely varying
rates [60]. Cardiac myocytes can increase, by three- to sixfold, the rate of cardiac power
generation, myocardial oxygen consumption, and ATP turnover in the transition from
rest to intense exercise [61]. Nevertheless, at high work states the myocardial ATP and
ADP concentrations are maintained at a relatively constant level despite the increased
turnover rates [34,62].
Specific β-cell respiratory mechanisms can be illustrated by comparing isolated mito-
chondria from skeletal muscle and cultured β-cells. The rate of respiration was higher
(>5.5 fold) and the relative leak rate was significantly lower at any Ψm value in isolated
mitochondria from skeletal muscle than in those from cultured β-cells [24,25]. We exam-
ined how these differences effect mitochondrial function by simulating the conditions of
work in muscle mitochondria (Figure 3). Mitochondrial NADH and cytoplasmic ADP
concentration are maintained at a relatively high and constant level in muscle cells
[34,62]. To simulate this, the concentration of [NADH]m was set as a constant reflecting
this concentration for high glucose level in a β-cell (25 mM). [ADP]c was also set to an
elevated constant level (700 mM), that was 5-fold higher than the calculated [ADP]c level
(at 9 mM glucose) in β-cells.
Figure 3 shows the results of simulations in which the maximal rate of ETC (Vme) was
increased in steps. Mitochondrial F1F0 ATPase activity (Vmph) was unchanged. Simulated
Ψm and the rate of ATP production (Jph) were significantly increased with an increased
Vme, such that F1F0 ATPases work with maximal activity under these conditions (com-
pare Jph in Figure 2C and Figure 3). This can be explained by the high Ψm (more electro-
negative) as well as by the increased [ADP]c in simulated muscle cells in comparison with
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when Ψm was increased above 160 mV, since these levels of Ψm were saturating for F1F0
ATPase activity (Appendix, Figure 12).
This indicates that the F1F0 ATPase can work in muscle cells with maximal productiv-
ity during increased respiration activity because ADP concentration and Ψm are sup-
ported at relatively higher levels. It thus appears that a decrease in the efficiency of
mitochondrial energy production with decreased Ψm can lead to a relatively high degree
of control on the phosphorylation potential in β-cells, i.e. a change in Ψm leads to a large
change in Jph. Interestingly, the simulated relative leak (Jh1) magnitude was significantly
lower in the muscle cell simulation in comparison with respiration rate (evaluated as
Jhres) at increased Vme even with invariant coefficients for the proton leak, since the rates
of respiration and ATP production were highly increased but a coefficient of leak (Jh1)
would remain as constant (Figure 3).
Our simulations help explain the data of Affourit and Brand [24,25] showing decreased
respiratory and increased relative leak activity in isolated β-cell mitochondria. This sug-
gests that mitochondrial glucose sensitivity in β-cells results from decreased respiratory
activity compared with F1F0 ATPase activity. This leads to mitochondrial work at
decreased Ψm that is in the region where variations in Ψm should result in an increased
sensitivity to glucose. Decreased respiratory activity in β-cells leads to a decreased ATP
production rate by the F1F0 ATPase. However, this gives β-cells the ability to adaptively
change the ATP/ADP ratio in response to changes in glucose concentration.
Figure 3 Comparison with muscle cell mitochondria. To compare β-cell and muscle cell mitochondria 
function we increased step by step the maximal rate of respiration (Vme, Equation 5) from basal β-cell level (ar-
row) (Table 3) and calculated the respiration rate (as Jhres), phosphorylation rate (as Jph), leak (Jhl) and Ψm in re-
sponse to the maximal rate of proton pumping through the ETC (Vme). Coefficients for F1F0 ATPase activity were 
unchanged. [NADP]m (1570 μM) and ADP (700 μM) were set to be constant at high levels. Note the rate of ATP 
production (represented as Jph) increased significantly as well as Ψmwith an increase of the maximal rate of res-
piration (compare with Figure 2). All other parameters were set as in Figure 2.
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lower in pancreatic islets even in high glucose, compared with brain or heart [7], sup-
porting our suggestion regarding decreased respiratory activity in β-cells.
Changes in leak activity and the role of uncoupling agents
Our model features increasing proton-leak with increased Ψm (Equation 8, Appendix).
We simulated how changes in leak activity affect the response of the variables. To do this
we increased the regulated coefficient of proton leak (P1r in Equation 8, Appendix) three-
fold leading to an increase in the total proton leak rate by twofold (Figure 4). As
expected, one effect was to reduce the inner membrane potential that causes a corre-
sponding right-shift in the ATP/ADP ratio and [Ca2+]c response to glucose. To simulate
decreased leak activity (for example following decreased uncoupling protein expression)
we set the regulated proton leak coefficient equal to zero in Equation 8 (P1r = 0) (Figure
4). In this way the general leak activity was decreased by 50%. Decreased leak activity
increased Ψm and reduced the sensitivity range of the inner membrane potential to glu-
cose leading to a left-shift in the ATP/ADP ratio and [Ca2+]c response.
These simulations show that proton leak can modulate GSIS by shifting the depen-
dence on glucose of the ATP/ADP ratio and [Ca2+]c, altering cellular sensitivity to glu-
cose challenge. This effect of proton leak is only possible when the ATP/ADP ratio can
be regulated by changes in Ψm, i.e. when Ψm lies below the β-cell maximal level for ATP
Figure 4 Effect of increasing glucose at different leak activity. A. [Ca2+]c; B. Ψm. To simulate the increase 
leak activity we magnified the proton leak rate twofold by increasing Plr (Plr = 0.0036 μM ms-1) in Equation 8. As 
expected, one effect was to reduce the inner membrane potential, and thus the ATP/ADP ratio. To simulate the 
decreased leak activity we diminished the proton leak rate twofold by decreasing Pir in Equation 8 (Pir = 0.0 μM 
ms"1) (see text for explanation). All other parameters were set as in Tables 2 and 3.
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above) and changes in Ψm exert an insignificant effect on the ATP production rate.
This role of uncoupling agents can be illustrated by considering the experimental data
for the principal β-cell uncoupling protein 2 (UCP2) (see for review [63,64]. For example,
overexpression of UCP2 in normal rat islets diminished the change in mitochondrial
membrane potential in response to glucose, reduced cytoplasmic ATP content, GSIS and
mitochondrial ROS production [65,66]. β-cells exposed to free fatty acids displayed a
lower mitochondrial membrane potential (less electronegative) and a decreased glucose-
induced hyperpolarization. These effects were due to increased activity of UCP2 [67].
Conversely, UCP2-deficient mice demonstrated increased ATP production and
improved GSIS [66]. In pancreatic islets from wild type but not Ucp2-knockout mice,
genipin, a cell-permeant compound that was reported to inhibit UCP2-mediated proton
leak, increased the mitochondrial membrane potential and cytosolic ATP, closed KATP
channels, and stimulated insulin secretion [68].
Our simulation gave similar results (Figure 4), showing that at a constant glucose level,
increased uncoupling protein activity leads to decreases in Ψm, the ATP/ADP ratio and
[Ca2+]c. However, our simulation also shows a novel aspect of this problem: an ability of
uncoupling proteins (and other uncoupling agents) to shift the glucose dependence of
the ATP/ADP ratio and [Ca2+]c. This shifting mechanism is not simply varying the rates
of a few processes. In our model, the shifting mechanism is generally characterized by
small changes in Ψm, ATP/ADP ratio or [Ca2+]c at low and high glucose levels. However,
larger changes of [Ca2+]c can be expected in the region of physiological glucose concen-
trations (Figure 4), a hypothesis that needs to be further tested.
The shifting set-point mechanism would regulate insulin secretion particularly during
a fluctuating nutrient supply. For example, UCP2 has been shown to be both induced
and activated by exposure of rodent islets to high free fatty acids that cause mild uncou-
pling [64,67,69,70]. According to our analysis uncoupling can lead to a right shift in the
glucose dependence of the ATP/ADP ratio and [Ca2+]c. This shift can result in decreased
insulin secretion at moderate levels of glucose and at high levels of free fatty acids in
blood. It may be a mechanism for restricting glucose consumption under conditions of
increased serum fatty acid concentrations, when muscle cells can use free fatty acids as
fuel rather than glucose.
Interestingly, this may be a physiologically important mechanism to blunt insulin pro-
duction in starved animals even without increasing free fatty acid concentration. During
starvation homeostatic mechanisms attempt to maintain a minimal acceptable blood
glucose concentration, in part to maintain neurons that cannot use free fatty acids. Star-
vation induces UCP2 expression and reduces cellular NADH generation in response to
glucose in mouse β-cells that would limit insulin secretion to reduce glucose uptake in
muscle and adipose cells [71].
Our analysis supports an important role for uncoupling agents in β-cells that can coor-
dinate the appropriate response of β-cells to fluctuating nutrient supply (see for example
[24,63]. However, a pathological side effect might also accompany shifting ATP/ADP
ratio and [Ca2+]c sensitivity to glucose, because decreased sensitivity of insulin secretion
in response to glucose is a characteristic property of Type 2 diabetes [27,37]. Simulation
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lead to a failure of β-cells to properly respond to glucose.
Role of Lactate dehydrogenase (LDH) and lactate production
Since β-cells have low levels of LDH (see Introduction) [1,14,15], we included a low level
of LDH activity under basal conditions (Appendix). This led to a small lactate flux within
the cytoplasm at low and medium glucose levels in our simulations (Figure 2A). How-
ever, the simulated lactate production increased significantly in response to high glu-
cose. This can be accounted for by increased [NADH]c/[NAD+]c (see Equation 3,
Appendix).
We also simulated a rise in LDH activity (Figure 5). This led to accelerated conversion
of pyruvate to lactate, that decreased NADH production in mitochondria from pyruvate
and the corresponding [NADH]m, Ψm, ATP/ADP ratio as well as [Ca2+]c in response to
increased glucose. This was all a consequence of the increased fraction of the glycolytic
flux that was directed to lactate production.
Our simulations confirm that low levels of LDH expression in insulin-secreting cells
are important for the correct channeling of pyruvate towards mitochondrial metabolism
(see [1,16]). However, we also found that net lactate production increases significantly
when extracellular glucose is increased (see Figures 2 and 5). For this reason, even low
LDH activity can be an effective safeguard to prevent mitochondrial overexcitation at
high glucose levels, where [Ca2+]c concentration is already saturated and increased Ψm
can lead to increased ROS production (see below).
Figure 5 Model parameters in response to changes of lactate dehydrogenase activity (VLDH). A. [Ca2+]c 
at different glucose levels. Low glucose level was 7 mM, medium was 9 mM and high was 20 mM; B. Depen-
dence of Ψm, Jpyr and JLDH at a medium glucose concentration ([Glu] = 9 mM). Arrow corresponds to VLDH (Equa-
tion 3) for basal level of coefficient (Table 3). All other parameters were set as in Figure 2.
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to glucose as measured by mitochondrial NAD(P)H, Ψm, cytosolic free ATP and Ca2+
and led to a right shift in the glucose response of insulin secretion [16], all of which are
simulated by our model. Since islet levels of LDH were increased in a rat pancreatectomy
model of type 2 diabetes [72] and β-cell lines such as INS-1 have increased LDH activity
that can partially explain their decreased sensitivity to glucose [14], overexpression of
LDH may also be a possible mechanism of β-cell failure in specific cases.
Role of NADH in cytoplasm and shuttle activity
The free cytoplasmic [NAD+]c/[NADH]c ratio can vary from about 700:1 to 200:1 in rat
liver [73]. Zhang et al. [74] measured free [NAD+]c/[NADH]c in Cos7 cells and found a
ratio of 644. Patterson et al. [47] found that the NAD(P)H concentration (NADH plus
NADPH) was much lower in the cytoplasm than in mitochondria in pancreatic islets.
Our calculations for the basal [NAD+]c/[NADH]c ratio level (Figure 2B) yield a magni-
tude of about 750:1 (at a glucose of 9 mM). Generally, our simulated [NAD+]c/[NADH]c
ratios were in the range of experimentally observed values. As free NAD+ levels greatly
exceed those of NADH, large changes in the [NAD+]c/[NADH]c ratio do not require cor-
respondingly large changes in free [NAD+]c. Thus, changes in cytoplasmic redox level
could be manifested primarily through variation in [NADH]c.
Pyridine nucleotides are not only key molecules for metabolic conversions, but also
can serve as critical signaling molecules, such as the cytoplasmic NAD(P)H/NAD(P)+
ratio [2,42,53,75]. Here we have focused only the energetic aspects of pyridine nucle-
otides and modeling. Generally, redox shuttles are responsible for maintaining and
restoring cytoplasmic NAD(P)H/NAD(P) + ratios and the cytoplasmic/mitochondrial
redox state in pancreatic β-cells (see Introduction). NADH generated by glycolysis was
efficiently reoxidized by highly active mitochondrial shuttles rather than by lactate dehy-
drogenase in basal conditions in our model (flux JTNAD is considerably higher than JLDH in
Figure 2A). Steady-state simulation was designed to investigate a role of the redox shut-
tles in cytoplasmic and mitochondrial events following a step change in the transport
rate coefficient for NADH shuttles at several glucose levels (Figure 6).
The result of this simulation showed that [Ca2+]c quickly reached saturation with
increased shuttle activity from the basal level. However, a decrease in transport rate coef-
ficient (TNADH) resulted in a decrease in ATP/ADP ratio and in [Ca2+]c from the apparent
threshold (Figure 6A). Failure to activate NADH-NAD+ transport between the cytosol
and mitochondria does not significantly alter the mitochondrial [NAD+]m/[NADH]m
ratio but significantly increases the cytosolic [NADH]c/[NAD+]c ratio, since [NADH]c
increases quickly with decreased TNADH (Figure 6B). Increasing the [NADH]c/[NAD+]c
ratio led to an acceleration of lactate production from pyruvate (Equation 9, Appendix).
The corresponding reduction in pyruvate concentration decreased mitochondrial ATP
production, leading to a decreased ATP/ADP ratio and decreased [Ca2+]c. However, glu-
cose consumption did not decrease significantly, because excess glucose influx was
shifted to accelerated lactate production in the cytoplasm, as a consequence of the sharp
increase in the cytoplasmic NADH concentration (Figure 6). This in silico study shows
that the cytosolic NADH transport into the mitochondria can be a key regulator of cyto-
solic NADH/NAD+ and lactate production in pancreatic β-cells only when its influx rate
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simulation of the shuttle system in cardiomyocytes [76].
The model simulations on the role of shuttles are also similar to published data. For
example, in islets deficient in glycerol-3-phosphate dehydrogenase (GPDH) (which
would effectively eliminate the glycerol-phosphate shuttle), when the malate-aspartate
shuttle was blocked by inhibiting aspartate aminotransferase by aminooxyacetate, glu-
cose-induced increases in cellular ATP content were impaired and insulin secretion was
eliminated, whereas the glycolytic flux remained unchanged [19]. However, studies of
this mGPDH-/- mouse model also show that neither absence of the glycerol-phosphate
shuttle (in mGPDH-/- islets) nor suppression of the malate-aspartate shuttle alone (in
wild-type islets) altered ATP synthesis or GSIS [19]. Our simulations (Figure 6) suggest
an explanation for these interesting results. Decreased shuttle activity did not lead to a
change in [Ca2+]c, if the TNADH initial value was close to a saturated level, and only signif-
Figure 6 Model parameters in response to changes of the transport rate coefficient for NADH shuttles 
(TNADH). A: [Ca2+]c at different glucose levels. B: Ψm, [PYR], [NADH]c and [NADH]m at medium glucose level (9 
mM); C: 2 Jglu, JPYR, JLDH and JTNADH at medium glucose level (9 mM). Arrow corresponds to TNADH (Equation 9) for 
basal level of coefficients (Table 3).
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of [Ca2+]c, whereas the glucose consumption remained unchanged.
The effects of agents known to increase shuttle activities were also examined. Shuttle
agonists increased the average [Ca2+]c in mouse islets in the presence of 12 mM glucose
[18]. Adenoviral overexpression of the protein Aralarl, a Ca2+ sensitive member of the
malate-aspartate shuttle, in both insulin-secreting INS-IE cells and rat pancreatic islets,
enhanced glucose-evoked NAD(P)H autofluorescence, Ψm and insulin secretion. Glu-
cose oxidation was enhanced and lactate production was reduced [77]. These experi-
mental results are in reasonably good agreement with the simulated [Ca2+]c, Ψm and
[NADH]m increases and decreased lactate output (JLDH) in Figure 6 when TNADH was
increased from the basal level.
Interestingly, activity and expression of the key enzymes of NADH shuttles were found
to be significantly decreased in fetal rat and pig islets compared with adult islets. This
can contribute to the inability of fetal β-cells to secrete insulin robustly in response to
glucose [78]. Activity of mGPDH, the key enzyme in the glycerol phosphate shuttle, was
reduced in islets from patients with type 2 diabetes [79], and it follows that decreased
levels of NADH shuttle activity could also be a possible contributor to β-cell secretory
failure [27]. Our simulations confirm the possibility that substantial decreases in activity
of NADH shuttles can result in secretory failure of β-cells. In this case our model also
predicts an increased lactate production rate in β-cells.
Role of mitochondrial Ca2+ handling in β-cells
Calcium signaling is associated with mitochondrial uptake of Ca2+ [10]. Recent islet stud-
ies have shown steady state resting mitochondrial [Ca2+]m levels are relatively low. Cali-
brated resting [Ca2+]m in rat islets was approximately 250 nM at 3 mM external glucose.
Increasing glucose to 16 mM resulted in a rise of cytoplasmic and mitochondrial [Ca2+]
above its resting level [48,50]. The simulated increase of [Ca2+]m versus glucose concen-
tration for steady-state (Figure 2E) was in agreement with these experimental data.
We explored the parameter space with respect to the mitochondrial Na+/Ca2+ anti-
porter rate to simulate a change of [Ca2+]m. We simulated inhibition and activation of the
Na+/Ca2+ exchanger velocity at medium glucose level that resulted in changes in [Ca2+]m
at steady-state (Figure 7). We analyzed several aspects of the possible role of [Ca2+]c in
regulating mechanisms comparing of the experimental evidences and our simulations.
1. Mitochondrial Ca2+ as an accelerator of ATP production
Mitochondrial Ca2+controls the key rate-limiting steps in the TCA cycle through activa-
tion of pyruvate dehydrogenase and at least two TCA cycle enzymes: isocitrate dehydro-
genase and α-ketoglutarate dehydrogenase (reviewed in [80]) and F1F0 ATPase [11]. A
control hypothesis emerged from this discovery [81]. According to this hypothesis an
increase in glucose concentration is accompanied by a rise in cytoplasmic Ca2+, and the
subsequent effect of matrix Ca2+ on the TCA cycle increases the supply of reducing
equivalents (NADH, FADH2) leading to a "push" of electrons through the respiratory
chain. This accelerates ATP production by generating more proton motive force, leading
to increased [NADH]m and stimulating oxidative phosphorylation [9,81].
However, a dominant role of [Ca2+]m in a control of β-cell oxidative metabolism under
physiological conditions is questionable. The initial mitochondrial NADH and Ψm
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increase in glucose [3,20,21,50]. In addition, respiration rate and insulin secretion can
initially follow the glycolytic rate, which is determined by glucokinase activity, rather
than by [Ca2+]m increase (see [10]). For this reason, it was proposed that Ca2+ is more
involved in the maintenance rather than in the initiation of glucose metabolism-secre-
tion coupling. At high glucose, glycolysis may become sufficiently fast such that pyruvate
oxidation becomes rate limiting in the formation of ATP or glucose-derived intermedi-
ates [41,52]. Under this limitation, positive regulation of mitochondrial metabolism can
require additional Ca2+ activation for the synthesis of ATP and other coupling factors
(see [10]).
Because [Ca2+]m can be regulated by mitochondrial Na+/Ca2+ exchanger activity, inhi-
bition of the Na+/Ca2+ exchanger was suggested as a possible target to increase [Ca2+]m
and thereby improve insulin secretion in type 2 diabetes. An inhibitor of the exchanger
(CGP37157) was shown to prolong mitochondrial Ca2+ signals and increase insulin
secretion [82]. (However, this inhibitor could block plasma membrane Ca2+ channels at
high concentrations [83]).
Our model allows an evaluation of the influence of [Ca2+]m changes on GSIS. The
results of simulations (Figure 7) showed that increasing mitochondrial [Ca2+]m by inhib-
iting the Na+/Ca2+antiporter did not initially lead to any changes in mitochondrial fluxes
Figure 7 Model parameters in response to changes of the maximal Na+/Ca2+ antiporter rate (VmNc). A: 
[Ca2+]c and [Ca2+]m; B: respiration rate (Jhres), phosphorylation rate (Jph), leak (Jhl) and Ψm. Arrow corresponds to 
VmNc (Equation 11) for basal level of coefficients (Table 3). Calculations were performed at medium glucose level 
(9 mM).
Fridlyand and Philipson Theoretical Biology and Medical Modelling 2010, 7:15
http://www.tbiomed.com/content/7/1/15
Page 18 of 44or the corresponding increase in the ATP/ADP ratio and [Ca2+]c at all glucose levels eval-
uated. The initial decrease of [Ca2+]m due to an increased maximal velocity of Na+/Ca2+
also did not lead to significant changes in the ATP/ADP ratio and [Ca2+]c (Figure 7). We
found that the reason for such insensitivity to [Ca2+]m was that [Ca2+]m was above the
threshold for activation of mitochondrial processes even at basal conditions. Our simu-
lations showed that the respiration rate and insulin secretion may follow the glycolytic
rate at physiological conditions, rather than an increase in [Ca2+]m (see above).
However, a large decrease in [Ca2+]m due to a large increase in the maximal velocity of
Na+/Ca2+ exchange led to an inhibition of ATP production and a decreased ATP/ADP
ratio and [Ca2+]c (Figure 7). Our simulations also suggest that an increase in GSIS can be
expected following increased [Ca2+]m, for example, following inhibition of the Na+/Ca2+
exchanger but only if the initial [Ca2+]m is so low as to limit mitochondrial reactions. The
effect of [Ca2+]m on activation of mitochondrial processes in β-cells should therefore be
further tested specifically under hyperglycemic and hyperlipidemic conditions.
2. Mitochondrial Ca2+ influx as a suppressor of ATP production
Physiological influx of Ca2+ into the mitochondrion can cause a measurable concurrent
mitochondrial depolarization [84]. Ca2+ cycling in mitochondria reflects the uptake of
Ca2+ electrogenically coupled to the efflux of Ca2+ in exchange for protons or sodium
ions. This effectively results in uncoupling and would be included in proton leak mea-
surements (Equation 18, Appendix). A high mitochondrial Ca2+ influx and efflux equiva-
lent to an increased proton leak would cause a fall in membrane potential. This would
shut down ATP production by the F1F0 ATPase, a process referred to as "short circuiting"
in the several mathematical models for β-cell mitochondria in [29,30,85]. In these mod-
els the uptake of Ca2+ by β-cell mitochondria suppressed the rate of production of ATP
via oxidative phosphorylation.
However, the conclusion that mitochondrial Ca2+ cycling leads to energy dissipation in
the pancreatic β-cell is not supported by experimental data which actually favors the
opposite idea, that the primary role of mitochondrial Ca2+ is the stimulation of oxidative
phosphorylation [9]. The contribution of Ca2+ cycling to proton leak was estimated to be
only about 1% of the state 3 rate [9,86]. Mitochondrial Ca2+ cycling also does not lead to
marked energy dissipation in the heart [87]. Recordings in mouse islet cells revealed no
effect of the inhibitor of the Na+/Ca2+ exchanger (CGP-37157) on the hyperpolarized Ψm
under glucose-stimulated conditions [83] suggesting that mitochondrial Ca2+ cycling
likely does not make a major contribution to energy dissipation. Our simulation shows
increased ATP production coincidentally with increased [Ca2+]c does not decrease Ψm
(Figure 2). The contribution of Ca2+ cycling to the fluxes that result in a dissipation of Ψm
was less than 1% in our model. This is due to low activity of the Ca2+ uniporter and Na+/
Ca2+ exchanger that we have employed to approximate the observed delay between the
oscillations [Ca2+]c and [Ca2+]m in β-cells in vivo (see Appendix). The overestimation of
the role of Ca2+ fluxes in the dissipation of Ψm in β-cell models [28-30,85] may have
arisen from the overestimation of mitochondrial Ca2+ fluxes taken from data obtained on
isolated mitochondria.
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The role of mitochondrial Ca2+ handling in the regulation of cytoplasmic Ca2+ concen-
tration has been emphasized in several cell types [9]. Mitochondria are an important
storage component for Ca2+ handling in cardiomyocytes, where fast and large cytoplas-
mic Ca2+ changes define cardiac excitation-contraction coupling [87,88]. However, an
estimation of the subcellular compartmental volumes of cardiomyocytes gave 58.5%
cytosolic and 36% mitochondrial volumes, respectively [89]. On the other hand, β-cell
mitochondrial volumes ranged from only 4% to 8% per cell [90,91]. This greatly limits
the degree to which mitochondria can regulate cytoplasmic Ca2+ concentration in β-
cells.
Ca2+ influx through L-type Ca2+ channels and efflux through plasma membrane
pumps, along with endoplasmic reticulum (ER) stores are the principal regulators of β-
cell cytoplasmic Ca2+ homeostasis [4,5,10,92,93]. A robust mitochondrial Ca2+ pool was
not a necessary component of our previous model examining regulation of cytoplasmic
Ca2+ homeostasis (see [5,26]). The mitochondrial Ca2+ pool is significantly smaller com-
pared with the ER free Ca2+ pool, because the ER volume can be up to 20% of total β-cell
volume [90] and its free Ca2+ concentration can reach several hundred mM (see Refs.
[4,5,92]). Given the smaller mitochondrial volume, our simulations did not show signifi-
cant Ca2+ fluxes between cytoplasm and mitochondria (see above). This raises the ques-
tion as to whether β-cell mitochondrial Ca2+ handling can play a significant role in the
regulation of β-cell [Ca2+]c under physiological conditions.
Variations in mitochondria operation rates and content
Reduction in mitochondrial metabolism and/or cellular content (number or volume) can
in principle underlie progression to the decreased insulin secretion typical of Type 2 dia-
betes [35,37,94]. For this reason, we employed our model to simulate the effect of
changes in mitochondrial functional activity and/or content.
1. Suppression of respiratory activity
We varied the maximal rate of ETC proton pumping (Vme) (Equation 5, Appendix) to
simulate of the results of experiments where the electron transport chain activity was
decreased (Figure 8). As expected, this simulation showed an increased [NADH]m with
decreased Vme, however, Ψm, ATP production, respiration rate, ATP/ADP ratio and
[Ca2+]c were also decreased. The glucokinase reaction rate was not changed because the
rate of pyruvate reduction by LDH was increased as a consequence of increased [Pyr].
This was due to increased [Pyr] and the part of glycolytic substrate that was not used for
ATP synthesis was removed by increased lactate production (not shown).
These simulations correspond to data [95-97] obtained following inhibition of tran-
scription of mitochondrial DNA by ethidium bromide (EtBr), leading to a reduced
expression of the mitochondrial electron transport system. After EtBr treatment (in the
INS-1 β-cell line), Ψmfailed to hyperpolarize in response to glucose and ATP production
and insulin secretion were significantly decreased [97]. Noda et al. [96] found EtBr
caused increased NADH accumulation and lactate production in β HC9 cells, along with
decreased [Ca2+]c and ATP/ADP ratio. In contrast, glucose utilization was only insignifi-
cantly decreased.
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We varied also the maximal F1F0 ATPase activity (Vmph) (Appendix, Equation 7) to simu-
late of the results of experiments where this activity was changed. Suppression of F1F0
ATPase activity resulted in decreased of ATP synthesis in mitochondria. This decreased
[ATP]c and increased [ADP]c leading to a decreased ATP/ADP ratio and decreased
[Ca2+]c (Figure 9). Decreased proton flux rates through the F1F0 ATPase led to an
increase in Ψm. According to Equation 5C an increase in Ψm decreases ETC activity. This
decreased [NADH]m consumption lead to decreased respiration rate (measured as O2
consumption) (simulations not shown) and insignificant [NADH]m accumulation. Inter-
estingly, here as well as in first case, the rate of glucokinase reaction was not changed
Figure 8 Model parameters in response to changes of the maximal rate of proton pumping in ETC 
(Vme). [Ca2+]c, Ψm and mitochondrial NADH concentration were calculated for medium glucose level (9 mM). 
Arrow corresponds to the basal Vme (Table 3).
Figure 9 Model parameters in response to changes of the maximal rate of proton flux in F1F0 ATPase 
(Vmph). [Ca2+]c, Ψm, [ATP]c/[ADP]c and mitochondrial NADH concentration were calculated for medium glucose 
level (9 mM). Arrow corresponds to the basal Vmpe (Table 3).
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to increased Ψm (not shown).
These simulations correspond to the data obtained on BHE/cdb rats, which have a
mutation in ATP synthase that limits ATP production and leads to development of mild
diabetes [98,99]. BHE/cdb rat islets showed reduced responsiveness to glucose stimula-
tion and ATP content was lower than in control islets [99]. The authors suggested that
Ψm is increased in BHE/cdb rat islets due to increased oxygen radical formation [99].
GSIS was reduced, but could not be attributed to changes in glucokinase activity or islet
glucose uptake [100].
3. Changes in mitochondria activity or content
To simulate changes in mitochondrial activity or content we varied the mitochondrial
volume and corresponding maximum rate of the mitochondrial reaction fluxes in the
model (Figure 10). The simulation showed that decreased maximal rates of all intramito-
chondrial processes from the basal level, corresponding to decreased mitochondrial
Figure 10 Steady-state simulations of parameters in response to changes of mitochondria content. We 
simultaneously changed all maximal rates of mitochondrial processes (JPYR, Jhres, Jph, Jhl, jTNADH, Juni, JNCa)- The 
arrow corresponds to the basal maximal rates and mitochondrial volume from Tables 2 and 3 (shown on axis 
as 1). A: [Ca2+]c at different glucose levels. B: Ψm, [PYR], [NADH]c and [ATP]c/[ADP]c at medium glucose level (9 
mM); C: 2 Jglu, jPYR and JLDH at medium glucose level (9 mM). All other parameters were set as in Tables 2 and 3.
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trations, coincidentally with a decreased Ψm, ATP/ADP ratio and [Ca2+]c (Figure 10A,B).
The glucose consumption rate decreased moderately since the increase in [PYR] led to
an increase in lactate production (Figure 10C) that together with a decreased rate of
pyruvate decarboxylation in mitochondria led to an insignificant change in glycolytic
flux.
These model simulations for decreased mitochondrial activity or content are in accor-
dance with experimental data. For example, a pancreatic β-cell mouse model for mito-
chondrial diabetes induced by tissue-specific disruption of the nuclear gene encoding
the mitochondrial transcription factor A (Tfam) displayed severe mtDNA depletion,
deficient oxidative phosphorylation and abnormally enlarged islet mitochondria [101].
Tfam is essential for mtDNA expression and maintenance, β-cell stimulus-secretion cou-
pling in isolated islets from tfam -/- mice showed reduced hyperpolarization of the mito-
chondrial membrane potential, impaired Ca2+-signaling and lowered GSIS [101].
Similarly, β-cell specific disruption of Tfam led to 50% reduction in mRNA levels for the
mitochondrially encoded nd1 gene, a subunit of the NADH dehydrogenase comprising
complex I of the mitochondrial respiratory chain. As a consequence, total cellular ATP
concentration was drastically decreased by 75%, and glucose failed to augment cytosolic
ATP, explaining the blunted GSIS [102].
Simulation of increased mitochondrial content above basal levels leads to an initial
increase in [Ca2+]c at the tested glucose levels. This initial increase of [Ca2+]c is due to
increased ATP production (and an increase in ATP/ADP ratio) as a result of decreased
lactate production (see Figure 10C). Interestingly, our simulation shows decreased
[Ca2+]c following increased mitochondrial content, due to decreased ATP production
(with decreased ATP/ADP ratio) at low and medium glucose levels. This is a result of
increased total leak activity that occurs in the model as a consequence of increased mito-
chondrial content. According to the simulation, lactate production was higher and rela-
tive leak was lower (compared with electron transport rate) in basal conditions at high
glucose content. For this reason [Ca2+]c did not decrease with increased mitochondrial
activity or content at high glucose level ([Glu] = 20 mM) (Figure 10A).
While our simulations support the obvious result that a decrease in mitochondrial
function (or content) leads to decreased ATP production, ATP/ADP ratio and [Ca2+]c
response to glucose, together giving decreased glucose sensitivity (Figure 8, 9, 10), the
simulations also show that subtle variation in mitochondrial function or content could
underlie β-cell defects in type 2 diabetes (see [10,37,103]. On the other hand, increased
mitochondrial content can, in theory, initially increase β-cell sensitivity to glucose (Fig-
ure 10) especially if their initial content was decreased in comparison with basal levels.
This supports the idea that an increase in mitochondrial content can be a possible target
for treatment of type 2 diabetes.
Oscillation processes
Oscillations in cytoplasmic and mitochondrial metabolism, membrane potential, intrac-
ellular and mitochondrial Ca2+ due to increased glucose concentrations has been
described as a specific characteristic of glucose signaling in the β-cell [3,20-22,104]. The
source of these oscillations and the mechanism of orchestration are not clearly under-
stood and may reflect multiple processes [5,23,26,105]. Particularly, [Ca2+]c oscillations
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reason, the aim of this section is testing the hypothesis that independent [Ca2+]c oscilla-
tions can create coupled oscillations in metabolic processes.
We previously developed a mathematical model describing β-cell ion regulation that
shows how [Ca2+]c oscillations can be independently established from mitochondrial
processes when the ATP/ADP ratio achieved some threshold leading to initial depolar-
ization of the plasma membrane [5]. However, for ease of use here we employed a simpli-
fied mathematical model that created a periodically varied [Ca2+]c in the cytoplasm
(Equations 24-30, Appendix) (Figure 11A). Using this simpler model we simulated the
characteristic shape of slow [Ca2+]c oscillations (with a period of one minute and longer),
where [Ca2+]c increased sharply and the quiescent time was longer than the period with
increased [Ca2+]c (the experimental examples of such oscillations in β-cells are shown
Figure 11 Model-predicted dynamic responses of parameters in pancreatic β-cells for independent 
[Ca2+]c oscillations at 9 mM glucose concentration. A: independent [Ca2+]c oscillations (Appendix) and sim-
ulated [Ca2+]m transient in response to [Ca2+]c oscillations; B: Ψm, [ADP]c and [NADH]m; C: glucose consumption 
(Jglu, Equation 1) and oxygen consumption (JO2, Equation 6). All other parameters set points were taken for bas-
al conditions (Tables 2 and 3). Variations in the oxidative phosphorylation rate (as Jph) were determined in our 
model mainly by the [ADP]c changes (Equation 7) and this rate increased with [ADP]c increase following [Ca2+]c 
rise, that in turn decreased Ψm and increased O2 consumption rate.
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Page 24 of 44[5,23,106]). Our model simulated the corresponding changes in several β-cell mitochon-
drial and metabolic processes (Figure 11). This simulation showed that the metabolic
and membrane variables in the cytoplasm and mitochondrial matrix can display oscilla-
tory behavior when [Ca2+]c oscillated independently.
A mechanism involving periodic nucleotide concentrations links [Ca2+]c changes to
activation of metabolic oscillations. Each [Ca2+]c increase during oscillations leads to
increased cytoplasmic ATP consumption (Equation 20, Appendix). This decreases
[ATP]c and increases [ADP]c (Figure 11B) leading to a decreased ATP/ADP ratio. This
resulted in an amplification of ATP synthesis by the mitochondrial F1F0 ATPase (Equa-
tion 7A). Increasing the rate of proton flux through F1F0 ATPase led to a decrease in Ψm
(Figure 11B). According to Equation 5C (Appendix) a decrease in Ψm increases ETC
activity. This enhanced [NADH]m consumption and the respiration rate, measured as O2
consumption. For this reason, the electron transport and respiration rates were substan-
tially in phase with [Ca2+]c oscillations (Figure 11C). The oscillations in the glucose con-
sumption rate determined by glucokinase (Equation 1, Appendix), that follows the
[ATP]c changes, were out of phase with [Ca2+]c oscillations (Figure 11C).
The experimental data are in accordance with our model simulations. For example,
increased [Ca2+]c in MIN6 cells at constant glucose levels caused a fall in the ATP/ADP
ratio as inferred from an experiment tracking luciferase-generated photons in trans-
fected cells expressing luciferase [13]. Glucose-induced NAD(P)H and [Ca2+]c slow oscil-
lations were measured simultaneously in mouse pancreatic islets, revealing that
NAD(P)H oscillations were small and preceded those of calcium by about 0.1 of a period
[21]. In our model the mitochondrial NADH peak concentrations also slightly preceded
[Ca2+]c periodic maxima (see Figures 11A,B). The delay (about 9 sec) was about 0.1 of a
period of simulated [Ca2+]c oscillations.
Glucose-induced [Ca2+]c and Ψm slow oscillations have been reported [20-22,104], and
measured simultaneously in mouse pancreatic islets [20]. The results (Figure 4 from Ref.
[20]) were similar to the dependence that we calculated (Figures 11A,B).
Oscillations in islet oxygen and glucose consumption have also been recorded [95,107].
The glucose consumption rate was out of phase with slow [Ca2+] oscillations, and oxygen
consumption rate and [Ca2+]c changes were approximately in phase. The mechanism of
this phenomenon is as yet unknown. However, these data are in accord with our model
simulation (Figure 11A,C) and could be explained by decreased ATP and increased free
ADP concentrations with increased [Ca2+]c during the appropriate phase of slow oscilla-
tions.
Mechanisms other than [ADP]c changes can cause variations in [Ca2+]m. Because the
changes of Ψm were modest while [Ca2+]c varied with significant amplitude during oscil-
lations, an influx of Ca2+ into mitochondria is determined mainly by a change in [Ca2+]c
while Ca2+ efflux depended predominantly on [Ca2+]m changes in our model. This led to
some delay in [Ca2+]m oscillations in comparison with [Ca2+]c (14 sec in Figure 11A). The
value of this delay was used here to determine maximal rates of Ca2+ fluxes (PCa in Equa-
tion 10 and VNC in Equation 11, Appendix).
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oscillations in mitochondrial Ca2+ were in response to glucose elevations, presumably
tracking oscillations in [Ca2+]c [50,82,108,109]. Periodic oscillations in [Ca2+]m followed
[Ca2+]c oscillations with a delay of approximately 14 sec [50,109]. A similar delay between
the maxima of [Ca2+]c and [Ca2+]m (14 sec) was simulated in Figure 11A.
From these results, our simulations at least partially confirm a possible cycle of events
previously suggested whereby increased [Ca2+]c during oscillations results in a decrease
in ATP/ADP ratio due to increased ATP consumption [13,50]. In the next phase, when
[Ca2+]cdecreases, ATP production outweighs ATP consumption leading to an increasing
ATP/ADP ratio. However, this pathway is unlikely to be a possible pacemaker mecha-
nism for [Ca2+]c oscillations as has been proposed [13,50]). Rather this could serve as a
mechanism where cyclic changes in ATP/ADP ratio are determined by independent
cytoplasmic Ca2+ oscillations.
Oscillations in Ψm and mitochondrial NADH are usually small in amplitude in pancre-
atic β-cells [20-22,104]. Mitochondrial Ca2+ oscillations, on the other hand, are reason-
ably large.
However, they have a typical dynamic that is intrinsic to two successive components
where [Ca2+]m follows [Ca2+]c with a particular delay (see above). Our dynamic simula-
tions also clearly show that the independent [Ca2+]c oscillations lead to simulation of
[Ca2+]m, Ψm, mitochondrial NADH and respiration oscillations that were similar to
experimental observations. These experimental data and our simulations suggest that
independent [Ca2+]c oscillations can be a pacemaker in the generation of oscillations of
mitochondrial and cytoplasmic parameters in β-cells.
Regulation of ROS content in β-cells
In most cells mitochondria represent the main source of the physiological production of
reactive oxygen species (ROS), which may be a byproduct of ETC function [9,110], while
recent evidence suggests that NADPH oxidase-dependent generation of ROS in pancre-
atic β-cells [111] and ROS generation from sulfhydryl formation in proinsulin biosynthe-
sis [112] are also potentially important potential sources of ROS generation.
ROS production in mitochondria depends upon the redox state of the ETC complexes,
since the ETC carriers in a reduced state have the property of donating electrons to oxy-
gen [110]. The redox state of the ETC complexes and, consequently, the rate of superox-
ide production also highly depend on Ψm. The increased Ψm (above about 160 mV)
decreases electron transport capability leading to a reduced state of the carriers and
sharply increases ROS production [110,113]. A pronounced increase in Ψm also aug-
mented ROS production in pancreatic β-cells [36,70].
Interestingly, β-cells have relatively low levels of free radical detoxifying and redox-reg-
ulating enzymes such as superoxide dismutase, glutathione peroxidase, catalase and thi-
oredoxin [114,115]. The reasons for this are unclear, although it has been suggested ROS
may also subserve a signaling function [116]. However, despite the reported low expres-
sion of detoxifying and redox-regulating enzymes in β-cells, antioxidant systems appear
to be sufficient to prevent acute oxidative damage under normal physiological conditions
[114,115]. We can explain this intriguing property of β-cells based on our simulations
results, which show (Figures 2 and 3) that β-cells usually work at a relatively lower Ψm(<
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production and, consequently, β-cells require a decreased level of detoxifying and redox-
regulating enzymes, at least under "normal" conditions, as has been reported.
However, a decreased level of detoxifying and redox-regulating enzymes may also con-
tribute to increased sensitivity of β-cell mitochondria to damage when ROS production
increases above normal levels. For example, as was pointed out above, increased respira-
tory activity, decreased UCP content, decreased LDH activity or high glucose levels
could lead to increased Ψm and subsequently to increased ROS production. The imbal-
ance in ROS production versus protection can occur in β-cells more easily than in other
types of cells because of decreased level of detoxifying and redox-regulating enzymes.
For these reasons, an overload by metabolic secretagogues such as glucose, causing
increased insulin secretion following increase in Ψm and ATP/ADP ratio can also induce
increased oxidative stress as a result of elevated ROS production and decreased ability
for defense. This could quickly result in ROS-induced reduction in mitochondrial func-
tion and cellular content, decreased ATP synthesis, dysregulated calcium homeostasis
and ultimately cell death. Decreased mitochondrial functional activity or content could
lead to decreased glucose sensitivity and consequently can lead to type 2 diabetes
[36,37,117].
Conclusion
The integrated mathematical model of β-cell energetics constructed here has allowed us
to reproduce and suggest explanations for experimental relationships among Ψm, respi-
ration, NADH, mitochondrial and cytoplasmic Ca2+ and ATP/ADP ratio and other
parameters under various conditions. Our analysis shows that the control structure of β-
cell energetics is determined predominantly by the need to regulate the ATP/ADP ratio
to keep sensitivity to glucose within the physiological range.
Special features of glucose metabolism in pancreatic β-cells are central to enable this
physiological role. Three of these characteristics were emphasized in our model: the glu-
cose phosphorylation by the high-Km glucokinase, which is rate-limiting for glucose-sen-
sitive metabolism and determines the glucose dependency curves of many processes in
the β-cell; the remarkably low activity of LDH; and the presence of effective hydrogen
shuttles to allow virtually quantitative oxidation of glycolytic NADH (see above). Our
analysis is both influenced by and supports these proposals.
We found that the adaptive mechanisms in mitochondria can include decreased respi-
ratory activity compared with F1F0 ATPase activity. This mechanism leads to mitochon-
drial function in the region with decreased Ψm where variations in Ψm should result in
high sensitivity to physiological glucose levels and low ROS production. We found also
that proton leak allows fine adjustment and exerts a higher level of control by shifting the
ATP/ADP ratio and [Ca2+]c sensitivity to glucose.
This comprehensive model of β-cell energetics permits testing of bioenergetic control
hypotheses, provides a basis for further refinement of such steps as oxidative phosphory-
lation, mitochondrial Ca2+ handling and allow for future incorporation of other bio-
chemical pathways.
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Model of energetic and mitochondrial processes
The reaction network of the model is shown in Figure 1. Due to the large number of
reactions under consideration, the mathematical description is simplified as much as
possible and in some cases intermediate metabolites were lumped together. To help sim-
plify the mitochondrial currents and variables, we represented respiration and ATP syn-
thesis rates in terms of effective proton fluxes.
The parameters for the model are given in Tables 2 and 3 along with references to the
specific original studies. However, to achieve a closer correspondence with metabolism
in intact β-cells or islets we have modified some of these parameters to more closely
reflect the complex experimental measurements in vivo, where indicated.
Glucose uptake and glycolysis
When the concentration of glucose rises in the extracellular medium, the β-cells take up
glucose by means of a glucose transporter, GLUT2 and/or GLUT1. The uptake is rapid
and believed to effectively equilibrate the extracellular and intracellular concentrations
of the sugar [6]. The initial phosphorylation of glucose to glucose 6-phosphate (G6P) is
catalyzed by glucokinase (see Introduction).
In the absence of externally added pyruvate or other metabolites, β-cells are glycolytic.
For the breakdown of each G6P molecule, the overall reaction yielded two pyruvate mol-
ecules, the phosphorylation of three ADP molecules to form ATP and the reduction of
two NAD+ molecules to NADH. Glucose phosphorylation is the key limiting step for the
steady-state rate of glycolysis in β-cells. However, the overall rate of ATP synthesis at
high workloads can also be limited by glycolysis due to a decreased cytoplasmic NAD+
availability for glyceraldehyde 3-phosphate dehydrogenase [18,118].
We simulated the phosphorylation of glucose and glycolytic flux by equations for the
limiting enzymes. The glucokinase reaction was modeled as previously [26]:
where Jglu is the rate of the glucokinase reaction, Vmglu is the maximum rate of glucose
consumption, [Glu] is extracellular D-glucose concentration, [ATP]c is the cytoplasmic
ATP concentration, KmATP is the Michaelis-Menten constant, Kmgl is the glucose concen-
tration at which the reaction is half maximum, and hgl is the Hill coefficient.
We lumped several glycolytic reactions and simulated only the NAD+-dependent step.
The flux through glyceraldehydes 3-phosphate dehydrogenase (Jgpd) was assumed to fol-
low irreversible Michaelis-Menten kinetics, where a dependence on [NAD+]c/[NADH]c
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Page 28 of 44Table 2: Standard physical and cellular parameter values (see text for explanations)
Parameters Symbol Value Units Reference
Relative cytoplasmic volume per β-cell Vi 0.53 Ul [90]
Relative mitochondrial volume per β-cell Vmit 0.06 Ul [90,91]
Relative mitochondrial matrix volume Vmmit 0.0144 Ul Ad
Mitochondrial membrane capacitance for β-cells Cmit 1.812 μM mV-1 [136]
Faraday's constant F 96484.6 C mole-1 Physical constant
Valence of Ca2+ ZCa 2 Ul Physical constant
Fraction of free Ca + in Mitochondria fi 0.01 Ul [5]
Fraction of free Ca2+ in mitochondria fm 0.0003 Ul [28]
Cytoplasmic Na+ concentration [Na+]c 10000 μM [130]
Mitochondrial Na+ concentration [Na+]m 5000 μM [130]
Thermal voltage (RT/F) (37°C) Tv 26.73 mV Physical constant
Cellular adenine nucleotides concentration At 4000 μM [5]
Free pyridine nucleotides concentration in 
mitochondrial matrix
Ntm 2200 μM [123]
Free pyridine nucleotides concentration in 
cytoplasm
Ntc 2000 μM Ad
Ul, unitless, Ad -Adjusted to fit glucose consumption rate and others conditions (see text).
where VmGPD is the maximal glyceraldehyde3-phosphate dehydrogenase activity, [G3P]
is the cytoplasmic glyceraldehydes 3-phosphate concentration, KmGPD is the Michaelis-
Menten constant, [NAD+]c and [NADH]c are the cytoplasmic NAD+ and NADH concen-
trations, and KGNc is the [NAD+]c/[NADH]c ratio that gives half maximal glycolytic flux
and NADH production.
Pyruvate reduction
The flux catalyzed by lactate dehydrogenase (JLDH) was described [119]:
where VmLDH is the maximal lactate dehydrogenase activity, [Pyr] is the cytoplasmic
pyruvate concentration, KmLD is the Michaelis-Menten constant, KLNC is the [NADH]c/
[NAD+]c ratio that gives half lactate and NAD+ production. Basal level of VmLDH was eval-
uated (Table 3) on the basis of the proposal that the rate of lactate output is approxi-
mately 5% of the rate of glucose consumption at [Glu] = 8 mM and other coefficients
were at their basal level.
Pyruvate dehydrogenase
The cytoplasmic pyruvate concentration is the key factor for mitochondrial ATP synthe-
sis. After being transported into the matrix of mitochondria, pyruvate is decarboxylated
in a process catalyzed by the multienzyme complex pyruvate dehydrogenase (PDH), thus
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Model 
parameters:
Value Units Eq. References
Vmglu 0.011 μM ms-1 1 Rescaled from Refs. [29,137]
KmATP 500 μM 1 [26]
Kmgl 7 mM 1 [26]
hgl 1.7 Ul 1 [26]
VmGPD 0.5 μM ms-1 2 Ad
KmG3P 200 μM 2 [138]
KgNc 0.09 Ul 2 [139]
VmLD 1.2 μM ms-1 3 Ad
KmLD 47.5 μM 3 [139]
kLNc 1 Ul 3 [139]
VmPDH 0.3 μM ms-1 4 [138]
Kmpyr 47.5 pM 4A [139]
KPNm 81 Ul 4B [139]
U1 1.5 Ul 4C [29]
U2 1.1 Ul 4C [29]
KCam 0.05 μM 4C [29]
vme 22 μM ms-1 5 Ad
KmNH 3000 μM 5A [123]
kAT -0.00492 mV-1 5C Fit to [24]
kBT -0.00443 mV-1 5C Fit to [24]
Vmph 8 μM ms-1 7 Ad
KmADP 20 μM 7A [26]
hph 2 Ul 7A [26]
hp 8 Ul 7B Ad
KPh 131.4 mV 7B Ad
KPCam 0.165 μM 7C [130]
Plb 0.0012 μM ms-1 8 Ad
Plr 0.0012 μM ms-1 8 Ad
klp 0.0305 mV-1 8 Fit to [24]
TNADH 0.05 μM ms-1 9 Ad
KTNm 16.78 Ul 9 [76]
KTNc 0.002 Ul 9 Ad
PCa 0.004 ms-1 10 Ad
am 0.2 Ul 10 [130]
ai 0.341 Ul 10 [130]
VmNC 0.025 μM ms-1 11 Ad
KNaj 8000 μM 11 [130]
KCaj 8 μM 11 [130]
kgpd 0.00001 ms-1 12 Ad
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form oxaloacetate (anaplerotic pathway) [120,121]. As in a previous model [30] we
assumed that the citric acid dehydrogenase rate is proportional to the reaction rate of the
PDH reaction. We assigned PDH a commanding role in the regulation of flux of glyco-
lytic metabolites into the TCA cycle. In this step NAD+ is also reduced to NADH, and
PDH activity is regulated by the availability of its coenzyme NAD+, i.e. its activity is
decreased when high ratios of NADH/NAD+ prevail [119]. Calcium also activates pyru-
vate dehydrogenase [80]. We described the rate of pyruvate consumption in mitochon-
dria (JPYR) as the product of several regulated factors:
where





kNADHm 0.0001 ms-1 14 Ad
kNADPc 0.0001 ms-1 16 Ad
kATP 0.00004 ms-1 20 Ad
kATP,Ca 0.00009 μM-1ms-1 20 Ad
[Ca2+]R 0.09 μM 23 Ad
kACa 0.25 μM 23 Ad
KAD 25 Ul 23 Ad
hCa 4 Ul 23 Ad
Ad -Adjusted to fit glucose consumption rate and others conditions (see text).
Table 3: Standard parameter values (see text for explanations) (Continued)
Figure 12 Relative steady-state ATP production activity with respect to Ψm. Relative rate of phosphoryla-
tion () was based on experimental data [131] for human cell line mitochondria (their Figure 2B, relative aver-
age values) and model fit to Equation 7B for AT (solid line).
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[NAD+]m and [NADH]m are the mitochondrial NAD+ and NADH concentrations, fPNAD
is the [NAD+]m/[NADH]m kinetic factors and FPCa is the calcium activity factor, and [Ca
+]m is the mitochondrial Ca + concentration.
Equations for fPYR and fPNAD are based on the Equation 18 from [119], KMPYR is a phe-
nomenological Michaelis-Menten constant, KPNm is the ([NAD+]m/[NADH]m ratio that
gives half maximal NADH production. Equation 18 from [29] was used for FPCa, where
u1, u2 and KCam are the parameters for fraction of activated PDH.
Electron transfer chain (ETC)
Ψm is maintained primarily by the action of respiration-driven proton pumps in the elec-
tron transport chain that use the energy contained in NADH and FADH2 to pump
hydrogen ions (H+) across the mitochondrial membrane out of the mitochondrial
matrix. This process depends on NADH, voltage and oxygen concentration.
As protons are pumped across the inner mitochondrial membrane oxygen is con-
sumed by the ETC. Thus, the respiration-driven proton flux is linked to O2 consumption.
Both NADH and FADH2 are electron donors, but in our model NADH is the primary
and dominant donor. Therefore we were able to omit a contribution from FADH2. We
described respiration in terms of an effective-driven proton flux. We based the equation
on the conceptual model [56] where the steady-state flux of electrons through the ETC
was represented as a product of several factors:
where
Jhres is the rate of proton pumping through ETC, Vme is the rate at optimal conditions.
FDe is the donor kinetic factor, fAe is the acceptor kinetic factors and, FTe is the thermody-
namic potential factor.
fDe was taken from the model [122]. Note that the apparent affinity of complex 1 for
NADH (KmNH in Equation 5A) is very low for in vitro measurements and does not corre-
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Page 32 of 44spond to the measured affinity in vivo [34]. For this reason, we used KmNH = 3 mM (Table
3) that corresponds to the value found for this reaction in vivo [123].
Acceptor kinetic factor (fAe) reflects the decrease in electron transport resulting from
diminished oxygen availability. In our model oxygen concentration is assumed to be sat-
urated and unlimited.
Thermodynamic potential factor (FTe) determines an inhibition of electron transport
with an increase in Ψm. This dependence was evaluated according to [24] where kAT and
kBT are coefficients that were fitted mathematically for mitochondria from muscle cells.
Cellular oxygen consumption rate is an indicator of mitochondrial electron transport.
Respiration rate was determined as O2 consumption (JO2). Then the oxygen consumption
rate (JO2) can be calculated as
The factor of 0.1 indicates that the full chain from NADH to oxygen is believed to
translocate ten protons per oxygen atom consumed where the H+/O ratios for oxidation
processes were assumed to be constant [124].
F1F0 ATPase
In an intact cell, under physiological high K+, a contribution of ΔpH to the protonmotive
force is usually small [125,126]. For simplicity, we suggest that the F1F0 ATPase uses pri-
marily the mitochondrial membrane potential to generate ATP from ADP and Pi by
allowing H+ ions to flow into the mitochondria. Some experimental evidence of this has
been reported [127]. The rate of proton flux through mitochondrial F1F0 ATPase (Jph)
was also described as the product of the several specific factors:
where
Vmph is the rate of the proton flux under optimal conditions. AD is the kinetic factor for
free cytoplasmic ADP, where [MgADPf]c is the concentration of free cytoplasmic
MgADP, KmADP is the activation rate constant, and hph is the Hill coefficient. AT is the
thermodynamic potential factor, where Kph is the membrane potential yielding half max-
J JO2 hres = 0 1. (6)
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Page 33 of 44imal ATP production, hp is the Hill coefficient. ACa is a sum of kinetic factors describing
the effect of calcium concentration, where KPCam is the [Ca +]m binding constant.
Since ADP concentration in mitochondria cannot be readily measured in living cells,
we used the dependence of AD on free MgADP in medium that can be calculated using
the Hill equation, where the mitochondrial oxidative phosphorylation rate increases
with increased free MgADP concentration. The apparent half-saturated concentration is
in the range of 20 - 45 μM and the Hill coefficient is about 2 [128,129]. Note that a supply
of ADP from cytoplasm is provided by the action of adenine nucleotide translocator
(ANT) on the mitochondrial inner membrane. We did not model this translocator
because Equation 7A includes the kinetic properties of ANT [128].
The thermodynamic potential factor (AT) can be represented as a sigmoid dependence
of ATP production on mitochondrial membrane potential [130]. However, in contrast to
[130] we used the data obtained by [131] for mammalian mitochondria to fit the coeffi-
cients for this dependence (Figure 12). The solid line shows the model fit where Kmp is
131.4 mV and Hill coefficient is 8. AT voltage dependence saturates when Ψm is above
160 mV. This dependence of ATP production on Ψm was similar for mitochondria from
muscle and β-cell [24]. Similar dependence of phosphorylation on Ψm was found for rat
liver mitochondria [132], and that is consistent with experimental findings for ox-heart
submitochondrial vesicles [133]. ACa is the again the sum of kinetic factors describing the
effect of Ca2+ [130]. Note that Jph increases with the electrical gradient (Ψm), the MgADP
concentration in cytosol and with the Ca2+concentration in mitochondria.
Proton leak
The mitochondrial membrane clearly leaks protons, decreasing the energy that can be
used to drive ATP synthesis. Up to 20% of the basal metabolic rate may be dissipated in
this basal leak, always present in mitochondria [124]. Part of the leak is also due to
uncoupling proteins (UCPs) that exist in mitochondria to uncouple oxidative phosphory-
lation, among other possible functions, and the level of their expression varies. To simu-
late the effect of UCPs we used a special regulated proton leak coefficient. The
dependence of the rate of proton leak back into the inner mitochondrial matrix on Ψm
was described as follows [24]:
Jhl is the proton leak across the mitochondrial inner membrane, Plb is the basal leak
coefficient, and Plr is the regulated leak coefficient, klp is the membrane potential coeffi-
cient.
We evaluated the basal leak coefficient in our model by supposing that the basal leak
approaches ~20% of the electron transport rate at 160 mV (see Table 3). We set the equa-
tion so that the coefficient Plr equals Plb for basal β-cell simulation (Table 3), leading to a
2-fold increase of Jh1 (i.e up to 40% of the electron transport rate at 160 mV).
NADH shuttles
Transport of the reducing equivalents derived from glycolysis in β-cells from the cytosol
to mitochondria in exchange for NAD+ is primarily through the glycerol phosphate and
the malate-aspartate shuttles [2,17]. These shuttles involve oxidation and reduction reac-
tions and include the enzymatic transporters. However, these processes have not been
Jhl lb lr lp mP P k= +( )exp( )Ψ (8)
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derived rate expression [76], where the shuttle activity is expressed as the function of
cytoplasmic and mitochondrial NADH/NAD+ ratios:
where TNADH is the transport rate coefficient, KTNc and KTNm are the affinity coeffi-
cients.
Ca2+ uniporter for uptake of Ca2+ into mitochondria (Juni)
Ca2+ influx into the mitochondria is mediated by the Ca2+ uniporter that is regulated by
the electrochemical gradient. This Ca2+ uniporter is not likely to be saturable by Ca2+
under physiological conditions and exhibits a half-activation constant for cytoplasmic
Ca2+ at concentrations greater than 10 μM [9]. The mitochondrial Ca2+ uniporter was
described according to [130] as
where PCa is the permeability of the Ca2+ uniporter, ZCa is the charge of Ca2+, [Ca2+]c is
the cytoplasmic Ca2+ concentration, αm, and αi are the mitochondrial and extramito-
chondrial activity coefficients.
Na+/Ca2+ exchanger for release of mitochondrial Ca2+ (JNCa)
In most cells, including pancreatic β-cells, the main mechanism of Ca2+ extrusion from
the mitochondria is the Na+/Ca2+ exchanger [9,82]. The expression for the Na+/Ca2+
exchanger was described according to [130] as
where
JNCa is the Na+ - Ca2+ exchange flux, VmNc is the maximal exchanger velocity, [Na+]c and
[Na+]m are the cytoplasmic and mitochondrial Na+ concentration, kNaj is the binding con-
stant for sodium and KCaj is the binding constant for Ca2+.
We set Ca2+ uniporter and Na+/Ca2+ exchanger maximum activity from experimental
data obtained for living cells. Delay was observed between changes in the cytosolic Ca +
J TNADH NADHT
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Page 35 of 44concentration and corresponding changes in [Ca2+]m [50,109]. This lag may reflect a
delayed response of the [Ca2+]m on [Ca2+]c changes. We have modeled this delay by set-
ting the maximal activities of the Ca2+ uniporter and the Na+/Ca2+ exchanger at levels
that replicate experimental slow [Ca2+]m dynamics (see text).
Dynamic equations
Finally, based on the above relations we determined the dynamic equations for cytoplas-
mic [G3P], [Pyr], [NADH]c and free [ADP] and the mitochondrial variables: [NADH]m,
[Ca +]m and Ψm- All fluxes were expressed as mass fluxes per unit time per unit total cell
volume.
The balance equation for the G3P concentration is
where kgpd is the rate constant of G3P consumption in cytoplasm, Vi is the relative
cytoplasmic fraction of total cell volume. Coefficient two in the numerator indicates that
the breakdown of each glucose molecule yields two G3P molecules.
Pyruvate is the main product of glycolysis. Due to lack of information on pyruvate con-
centrations at the sub-cellular level in β-cells, we do not differentiate the cytosolic and
mitochondrial pyruvate pools in this model. For simplicity, we assume that mitochon-
drial pyruvate is decarboxylated only in a process catalyzed by PDH. The equation
describing [Pyr] change over time is
where Vmmit is the relative mitochondrial matrix fraction of the cell volume.
In this model the TCA cycle is not explicitly modeled. However, it is known that under
steady-state conditions, four NADH and one FADH2 are synthesized in the TCA cycle
for each pyruvate molecule. To help simplify the mitochondrial variables in our model,
we evaluated the reducing equivalents (NADH and FADH2) in terms of H+ flux due to
pumping in the ETC. We assumed that 10 and 6 protons are pumped by each NADH and
FADH2 oxidation, respectively [124]. This means that one FADH2 can be represented as
0.6 NADH molecule.
We assumed that the NADH production rate in mitochondria is determined by the
reaction rate of pyruvate decarboxylation. The mitochondrial NADH concentration is
decreased by the action of the ETC, during which NADH is converted to NAD+ and oxy-
gen is consumed. The following equation describes the change in [NADH]m over time
where the stoichiometric coefficient 4.6 in the numerator arises from the number of
NADH molecules that are produced from each pyruvate molecule. The coefficient 0.1
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Page 36 of 44kNADHm is the rate constant of NADH consumption in mitochondria. The concentration
of pyridine nucleotides is assumed to be conserved in the mitochondrial matrix:
where Ntm is the total concentration of pyridine nucleotides in the mitochondrial
matrix (Table 2).
We assume also that the cytoplasmic concentration of pyridine nucleotides is con-
served. The balance equation for the cytoplasmic NADH and NAD+ concentrations is
where Ntc is the total concentrations of pyridine nucleotides in cytoplasm (Table 2).
kNADHc is the rate constant of NADH consumption in the cytoplasm.
Mitochondrial Ψm depends on the respiration module that establishes Ψm, negative
inside, and the dissipation processes: the activity of the phosphorylation apparatus,
which includes the phosphate carrier, the ATP synthase and the adenine nucleotide
translocase and proton-leak reactions. Another portion of Ψm drives Ca2+ out of the
matrix via the Na+/Ca2+ exchanger. Ca2+influx into mitochondria mediated by the Ca2+
uniporter is also electrogenic. The final equation for Ψm is
where Cmi is the mitochondrial membrane capacitance. The stoichiometric coefficient
2 in the numerator arises from the number of the charges that flow into mitochondria
with one Ca2+. We assumed that Ψm > 0.
The balance equations for [Ca2+]m is described by
where fm is the constant describing the fraction of free Ca2+ in mitochondria.
Several assumptions were made to simplify the ATP regulation model: (1) Due to the
rapid export of mitochondrial ATP to the cytosol via the ATP/ADP transporter no limi-
tation for this process was suggested. (2) ADP binding is in equilibrium (i.e. the binding
reactions are fast compared to the other processes included in the model of ATP
dynamic).
Utilization of ATP in the β-cells is mostly for ion transport, biosynthesis, and secre-
tion. The rate of ATP utilization is a complex function of the concentrations of ATP,
[Ca2+]c, glucose and numerous other factors, but almost nothing is known about the
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Page 37 of 44quantitative relation between them. Clearly, there is some basal level of ATP consump-
tion in a cell at low glucose and [Ca2+]c concentrations. There is evidence that ATP
hydrolyzing processes are accelerated during a glucose-induced increase in [Ca2+]c in β-
cells, for example, ATP consumption can be increased due to increased Ca2+ pump activ-
ity in the plasma membrane and endoplasmic reticulum [7,10,12,13]. For this reason,
two terms for ATP consumption were introduced: basal and Ca2+-dependent (see [5]).
Then, on the basis of the Equation 7 for oxidative phosphorylation we can write the bal-
ance equation for [ATP]c and [ADP]c
where
The factor of 2 in the numerator of Equation 20 (at Jglu) indicates that two ATP mole-
cules are produced during glycolysis from each glucose molecule. The coefficient 0.231
(at Jpf) arises from the ATP/H+ coupling stoichiometry of 3/13 in mammalian mitochon-
dria. This suggested as well the additional transport of one proton from the cytoplasm to
the matrix that is associated with the movement of phosphate through the mitochon-
drial membrane [124]; KATP is the permanent rate constant of basal ATP consumption,
and KATPca is the rate constant of ATP consumption that accelerates as Ca2+ increases.
The general concentration of intracellular nucleotides (A0) was assumed to be con-
stant. The constants KATP and KATP,Ca (Equation 20) were fitted to simulate both the low
and high glucose modeled rate of ATP production and ATP/ADP ratio in β-cells (see
[5,26]) (Table 3). The coefficient 0.055 in Equation 22 was calculated as in our previous
model [5,26].
External parameters
The mechanisms of [Ca2+]c and [Na+]c regulation and their interrelationships with other
metabolic and ionic fluxes are incompletely understood. For this reason in our model we
used their empirical determination as the external parameters, even though we previ-
ously developed a mathematical model for [Ca2+]c and [Na ]c regulation in β-cells [5,26].
[Na+]c was proposed as constant in this model (Table 2).
The relationship between [Ca2+]c and glucose at steady-state was calculated using the
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Page 38 of 44where [Ca2+]R is the constant [Ca2+] for resting low glucose, kACa is the coefficients,
KAD is the [ATP]c/[ADP]c ratio that gives half maximal [Ca2+]c, hCa is the Hill coefficient.
The parameters of Equation 23 were set to a value (Table 3) that produced a reasonable
amplification of [Ca2+]c with increased glucose (see Results and Discussion).
Model for independent cytoplasmic Ca2+ oscillations
We used a simple mathematical model that creates a periodically varied independent
[Ca2+]c change in cytoplasm to simulate the oscillations of the mitochondrial parameters
in β-cells. The model described in this section is based on a simple model [134] and used




gmVCa is the maximum conductance for IVCa (gmVCa = 20 μS), VP is the plasma mem-
brane potential.
Ca2+-activated K+ current (IKCa)
where
where gmKCa is the maximum conductance for IKCa, KKCa is the half-maximum Ca2+
binding constant for IKCa (gmKCa = 25 μS, KKCa = 0.25 μM).
The differential equation describing time-dependent changes in the plasma membrane
potential (Vp) is the current balance equation:
where Cm is the cell membrane capacitance (Cmp = 6158 fF [5])
The equations for [Ca2+]c dynamics can be written as:
IVCa mVCa Ca VCa Pg d f V= −∞ ∞( )100 (24)
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Page 39 of 44where fi is the fraction of free Ca2+ in cytoplasm, F is Faraday's constant, Vci is the vol-
ume of the cytosolic compartment in single cell (0.764 pL [5]), and ksg is the coefficient of
the sequestration rate of [Ca2+]c (ksg = 0.00002 ms-1 [5]).
Computational aspects
For computational purposes we considered the β-cell as an assemblage of mitochondria
with similar properties. The units used in the model are time in millisecond (ms), voltage
in millivolts (mV), concentration in micromoles/liter (μ, M), flux in μmol ms-1.
A factor (0.31) was used to convert picomoles per islet from metabolism experiments
to the cytoplasmic millimolar terms of a single β-cell (as calculated in Ref. [29]). The
mitochondrial protein density for total mitochondria volume is estimated at ~0.3 mg
protein/μl, and free water volume in mitochondrial matrix space can be estimated to be
0.24 of total mitochondria volume [135]. In line with these data we used the factor 1.25
to convert the measured nanomoles per milligram mitochondrial protein (nmol mg-1
protein) to mitochondrial matrix space in millimollar terms. In our model the fluxes
were specified for the volume of a cell. Multiplying the mitochondrial matrix volume
(Table 2) by its protein density (1.25 g protein ml-1) by unit flux [in nmol (mg protein
min-1)] gives the total flux in the mitochondria matrix per unit cell volume.
The general concentration of intramitochondrial and cytoplasmic adenine and purine
nucleotides were kept constant during simulations (Table 2). Model parameters were
found by several methods. Specifically, they were obtained from the scientific literature
when possible and were also found by fitting specific model equations to experimental
data. The third method was to estimate the parameter so that model variable values and
time courses closely matched experimental data. Several enzymatic activity values were
treated as adjustable parameters, which were adjusted using the reaction stoichiometries
to reflect the rate of glucose phosphorylation by glucokinase (Table 3). Parameter values
from Tables 2 and 3 were used unless otherwise mentioned. Nine ordinary differential
equations (Equations 12-14, 16, 18-20, 29, 30) describe the behavior of [G3P], [Pyr],
[NADH]m, [NADH]c, Ψm, [Ca2+]m, [ATP]c, Vp and [Ca2+]c. Coefficients are shown in
Tables 2 and 3. Calculations on Figure 12 and a generation of all figures were performed
using "Igor" (IGOR Pro, WaveMetrics, Inc, Lake Oswedo, OR, USA) and Microsoft Excel
X.
Simulations were performed as noted previously for an idealized mean individual cell
using the software environment from "Virtual Cell" (Fridlyand et al. [5,26]). To calculate
the steady-state cellular parameters, the model was allowed to run for at least 10s with
no external stimulation. Calculations obtained with the coefficients from Tables 2 and 3
have been mentioned in the text as a simulation at basal levels.
This model is available for direct simulation on the website "Virtual Cell" http://
www.nrcam.uchc.edu in "MathModel Database" on the "math workspace" in the library
"Fridlyand" with the name "GlucoseSensitivity-1" for the general model and with name
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ATP/ADP: ratio of ATP to ADP; ETC: electron transport chain; EtBr: ethidium bromide;
GK: glucokinase; Glu: glucose; GSIS: glucose-stimulated insulin secretion; G3P: glyceral-
dehyde 3-phosphate; KATP: ATP-sensitive K+ channels; LDH: lactate dehydrogenase;
PDH: pyruvate dehydrogenase; PYR: pyruvate; ROS: reactive oxygen species; TCA: tri-
carboxylic acid; Tfam: mitochondrial transcription factor A; UCP2: uncoupling protein
2; Ψm: mitochondrial membrane potential; Subscript c: cytoplasmic compartment; m:
mitochondrial compartment.
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